arthyperАртериальная гипертензия"Arterial’naya Gipertenziya" ("Arterial Hypertension")1607-419X2411-8524Antihypertensive League10.18705/1607-419X-2014-20-6-546-552arthyper-160Research ArticleЛЕКЦИЯLECTUREОПРЕДЕЛЕНИЕ И ДИАГНОСТИКА РЕЗИСТЕНТНОЙ ГИПЕРТЕНЗИИ: В ПОИСКЕ СОГЛАСОВАННЫХ РЕШЕНИЙDEFINITION AND DIAGNOSIS OF RESISTANT HYPERTENSION: SEARCH FOR A JOINT DECISIONГринштейнЮ. И.GrinshteinYu. I.

Доктор медицинских наук, профессор, заведующий кафедрой терапии института последипломного образования ГБОУ ВПО «Красноярский государственный медицинский университет имени профессора В. Ф. Войно-Ясенецкого» Минздрава России.

Контактная информация: Гринштейн Юрий Исаевич, ГБОУ ВПО «Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого» Минздрава России, ул. Партизана Железняка, д. 1, Красноярск, Россия, 660022. E-mail: grinstein.yi@mail.ru

Corresponding author: Yurii I. Grinshtein, MD, PhD, Professor, Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky, 1 Partisan Zheleznyak str., Krasnoyarsk, Russia, 660022. E-mail: grinstein.yi@mail.ru

grinstein.yi@mail.ruШабалинВ. В.ShabalinV. V.

Кандидат медицинских наук, доцент кафедры терапии института последипломного образования ГБОУ ВПО «Красноярский государственный медицинский университет имени профессора В. Ф. Войно-Ясенецкого» Минздрава России

grinstein.yi@mail.ruКрасноярский государственный медицинский университет имени профессора В. Ф. Войно-Ясенецкого, КрасноярскРоссияKrasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky, KrasnoyarskRussian Federation201406032015206546552Copyright © Гринштейн Ю.И., Шабалин В.В., 20152015Гринштейн Ю.И., Шабалин В.В.Grinshtein Y.I., Shabalin V.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://htn.almazovcentre.ru/jour/article/view/160

Резистентная гипертензия, распространенность которой достигает 10–15 % по различным данным, представляет собой артериальную гипертензию, не контролируемую на фоне приема комбинации оптимальных доз трех антигипертензивных препаратов, одним из которых является диуретик. В обзорной статье обсуждаются современные подходы к классификации резистентной гипертензии, алгоритма диагностики, дифференциальной диагностике, а также возможные причины недостижения целевого уровня артериального давления и пути преодоления резистентности к терапии. Особое внимание уделяется возможностям суточного мониторирования артериального давления в выделении специфических форм резистентной гипертензии и псевдорезистентности, определении истинной резистентной артериальной гипертензии и приводится алгоритм диагностики.

Resistant hypertension is defined as uncontrolled blood pressure on optimal doses of three antihypertensive agents, including a diuretic. According to the data from different studies, its prevalence achieves 10–15 %. The upto- date approaches to classification, diagnostic algorithms are discussed; the reasons of resistant hypertension are reviewed. Special attention is paid to the opportunities of ambulatory blood pressure monitoring in distinguishing particular forms of resistant hypertension and pseudoresistant hypertension; a specific diagnostic algorithm is presented. 

артериальная гипертензиярезистентная гипертензияпсевдорезистентная гипертензиясуточное мониторирование артериального давленияarterial hypertensionresistant hypertensionpseudoresistant hypertensionambulatory blood pressure monitoringReferencesCalhoun DA, Jones D, Textor S et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117(25): e510–26.Calhoun DA, Jones D, Textor S et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117(25):510–26.Calhoun DA, Booth JN 3rd, Oparil S et al. Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension. 2014;63(3):451–8.Calhoun DA, Booth JN, Oparil S et al. Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension. 2014;63(3):451–8.Judd E, Calhone DA. Apparent and true resistant hypertension: definition, prevalence and outcomes. J Hum Hypertens. 2014;28(8):463–8.Judd E, Calhone DA. Apparent and true resistant hypertension: definition, prevalence and outcomes. J Hum Hypertens. 2014;28(8):463–8.Daugherty SL, Powers JD, Magid DJ et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125(13):1635–42.Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125(13):1635–42.Sim JJ, Bhandari SK, Shi J et al. Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system. Mayo Clin Proc. 2013;88 (10):1099–1107.Sim JJ, Bhandari SK, Shi J, Liu IL, Calhoun DA, McGlynn EA et al. Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system. Mayo Clin Proc. 2013;88 (10):1099–1107.Dudenbostel T. Resistant hypertension — complex mix of secondary causes and comorbidities. J Hum Hypertens. 2014;28 (1):1–2.Dudenbostel T. Resistant hypertension — complex mix of secondary causes and comorbidities. J Hum Hypertens. 2014;28(1):1–2.Muxfeldt ES, de Souza F, Margallo VS et al. Cardiovascular and renal complications in patients with resistant hypertension. Curr Hypertens Rep. 2014;16(9):471.Muxfeldt ES, de Souza F, Margallo VS, Salles GF. Cardiovascular and renal complications in patients with resistant hypertension. Curr Hypertens Rep. 2014;16 (9):471.de la Sierra A, Segura J, Banegas JR et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57 (5):898–902.de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57(5):898–902.Kleman M, Dhaniamraji S, Difillippo W. Prevalance and characteristics of pseudohypertension in patients with “resistant hypertension”. J Am Soc Hypertens. 2013;7 (6):467–70.Kleman M, Dhaniamraji S, Difillippo W. Prevalance and characteristics of pseudohypertension in patients with “resistant hypertension”. J Am Soc Hypertens. 2013;7 (6):467–70.Brambilla G, Bombelli M, Seravalle G et al. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study. J Hypertens. 2013;31(10):2018–24.Brambilla G, Bombelli M, Seravalle G, Cifkova R, Laurent S, Narkiewicz K et al. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study. J Hypertens. 2013;31(10):2018–24.O’Brien E, Parati G, Stergiou G. Ambulatory blood pressure measurement: what is international consensus? Hypertension. 2013;62(6):988–94.O’Brien E, Parati G, Stergiou G. Ambulatory blood pressure measurement: what is international consensus? Hypertension. 2013;62(6):988–94.Crespo JJ, Fabbian F, Haus E, Manfedini R et al. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Chronobiol Int. 2013;30 (3):355–410.Crespo JJ, Fabbian F, Haus E, Manfedini R et al. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Chronobiol Int. 2013;30 (3):355–410.Hermida RC, Smolensky MH, Ayala DE et al. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Chronobiol Int. 2013;30(3):355–410.Hermida RC, Smolensky MH, Ayala DE et al. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Chronobiol Int. 2013;30 (3):355–410.Banegas JR, Ruilope LM, de la Sierra A et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J. 2014. doi: 10.1093/eurheartj/ehu016. [Electronic resource]. URL: http://eurheartj.oxfordjournals.org/content/early/2014/02/03/eurheartj.ehu016.abstract. Checked: 25.05.2014.Banegas JR, Ruilope LM, de la Sierra A, de la Cruz JJ, Gorostidi M, Segura J et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J. 2014. doi: 10.1093/eurheartj/ehu016. [Electronic resource]. URL: http://eurheartj.oxfordjournals.org/content/early/2014/02/03/eurheartj.ehu016.abstract. Checked: 25.05.2014.Mancia G, Fagard R, Narkiewicz K et al. 2013 practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31 (10):1925–38.Mancia G, Fagard R, Narkiewicz K et al. 2013 practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31 (10):1925–38.Okawa T, Obara T, Ohkubo T et al. Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: the J-HOME study. J Hypertens. 2006;24(9):1737–43.Okawa T, Obara T, Ohkubo T et al. Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: the J-HOME study. J Hypertens. 2006;24(9):1737–43.Muxfeldt ES, Salles GF. How to use ambulatory blood pressure monitoring in resistant hypertension. Hypertens Res. 2013;36(5):385–9.Muxfeldt ES, Salles GF. How to use ambulatory blood pressure monitoring in resistant hypertension. Hypertens Res. 2013;36(5):385–9.Xu T, Zhang Y, Xuerui T. Estimate of nocturnal blood pressure and detection of non-dippers based on clinical or ambulatory monitoring in the inpatient setting. BMC Cardiоvasc Disorders. 2013;13:37.Xu T, Zhang Y, Xuerui T. Estimate of nocturnal blood pressure and detection of non-dippers based on clinical or ambulatory monitoring in the inpatient setting. BMC Cardiоvasc Disorders. 2013;13:37.Weber F, Anlauf M. Treatment resistant hypertension — investiagation and conservative management. Dtsch Arztebl Int. 2014;111(25):425–31.Weber F, Anlauf M. Treatment resistant hypertension — investiagation and conservative management. Dtsch Arztebl Int. 2014;111(25):425–31.Denolle T, Azizi M, Massart C et al. Itraconazole: a new drug-related cause of hypertension. Ann Cardiol Angeiol. (Paris). 2014;63(3):213–5.Denolle T, Azizi M, Massart C, Zennaro MC. Itraconazole: a new drug-related cause of hypertension. Ann Cardiol Angeiol. (Paris). 2014;63(3):213–5.Чазова И. Е., Фомин В. В., Разуваева М. А. Резистентная и неконтролируемая артериальная гипертензия: проблема XXI века. Фарматека. 2011;218(5):3–8. [Chazova IE, Fomin VV, Razuvaeva MA. Resistant and uncontrolled arterial hypertension: a challenge of XXI century. Pharmateka. 2011;218 (5):3–8. In Russian].Chazova IE, Fomin VV, Razuvaeva MA. Resistant and uncontrolled arterial hypertension: a challenge of XXI century. RHarmateka. 2011;218(5):3–8. In Russian.Muxfeldt ES, Margallo VS, Guimaraes GM. Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension. Am J Hypertens. 2014;27(8):1069–78.Muxfeldt ES, Margallo VS, Guimaraes GM. Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension. Am J Hypertens. 2014;27(8):1069–78.

The authors declare that there are no conflicts of interest present.